Suchergebnisse - "Sarilumab"

PubPharm (55)

1

Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies : a phase III randomised trial (contRAst 3)

enthalten in: Annals of the rheumatic diseases | 2023

von Taylor, P. | Weinblatt, M. | McInnes, I. | +18

2

Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2023

von Burmester, G. | Strand, V. | Kivitz, A. | +5

3

Correspondence on : 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al

enthalten in: Annals of the rheumatic diseases | 2022

von Cheng, C. | Zhang, F.

CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1277-1285. - PMID 32620597

4

Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels

enthalten in: Joint bone spine | 2022

von Marotte, H. | Fakra, E. | Flipo, R. | +4

5

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis : results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis research & therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

6

Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Burmester, G. | Bykerk, V. | Buch, M. | +6

7

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients : A systematic review and meta-analysis

enthalten in: Reviews in medical virology | 2022

von Peng, J. | Fu, M. | Mei, H. | +5

8

Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema

enthalten in: Ophthalmology. Retina | 2022

von Deaner, J. | Jaffe, G. | Keenan, R. | +2

9

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19 : A network meta-analysis

enthalten in: PloS one | 2022

von Godolphin, P. | Fisher, D. | Berry, L. | +10

10

Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors

enthalten in: Rheumatology (Oxford, England) | 2021

von Fleischmann, R. | Genovese, M. | Maslova, K. | +3

CommentIn: Rheumatology (Oxford). 2021 Nov 3;60(11):4953-4955. - PMID 33974043

1
2
3
4
5
6
Nächster »
[6]